Company Growth (employees)
Cardiovascular Systems is headquartered in Saint Paul, US
Key People at Cardiovascular Systems
Scott R. Ward
Chairman, President & CEO
Laurence L. Betterley
CFO
Kevin J. Kenny
Chief Operating Officer
James E. Flaherty
CAO
Cardiovascular Systems Office Locations
Cardiovascular Systems has offices in Saint Paul and Rochester
Saint Paul, US (HQ)
1225 Old Hwy 8 Nw
Saint Paul, US
651 Campus Drive
Rochester, US
651 Campus Drive
Cardiovascular Systems Data and Metrics
Cardiovascular Systems Financial Metrics
Cardiovascular Systems's revenue was reported to be $178.2 m in FY, 2016 which is a 2% decrease from the previous period.
$, USD
Revenue (FY, 2016) | 178.2 m |
Revenue growth (FY, 2015 - FY, 2016), % | (2%) |
Gross profit (FY, 2016) | 142.8 m |
Gross profit margin (FY, 2016), % | 80% |
Net income (FY, 2016) | (56 m) |
EBIT (FY, 2016) | (56.1 m) |
Market capitalization (23-Jun-2017) | 1 b |
Closing share price (23-Jun-2017) | 30.8 |
Cash (30-Jun-2016) | 60.6 m |
Cardiovascular Systems's current market capitalization is $1 b.
| $, USD | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|
Revenue | 136.6 m | 181.5 m | 178.2 m |
Revenue growth, % | 33% | (2%) | |
Cost of goods sold | 31 m | 39.5 m | 35.4 m |
Gross profit | 105.6 m | 142 m | 142.8 m |
Gross profit Margin, % | 77% | 78% | 80% |
Operating expense total | 139.1 m | 174.7 m | 198.8 m |
EBIT | (33.5 m) | (32.6 m) | (56.1 m) |
EBIT margin, % | (25%) | (18%) | (31%) |
Net Income | (35.3 m) | (32.8 m) | (56 m) |
| $, USD | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|
Cash | 126.6 m | 83.8 m | 60.6 m |
Accounts Receivable | 21.4 m | 30.8 m | 23.1 m |
Inventories | 12.9 m | 14 m | 17.4 m |
Current Assets | 162.7 m | 133.9 m | 104.9 m |
PP&E | 15.3 m | 32.9 m | 32.5 m |
Total Assets | 181.9 m | 171.3 m | 142.4 m |
Accounts Payable | 12.7 m | 9.8 m | 8.5 m |
Current Liabilities | 29.7 m | 29.9 m | 35.5 m |
Non-Current Liabilities | 117 k | ||
Total Liabilities | 29.8 m | ||
Additional Paid-in Capital | 390.6 m | 410.7 m | 428.2 m |
Retained Earnings | (238.6 m) | (271.4 m) | (327.4 m) |
Total Equity | 139.4 m | 100.9 m | |
Financial Leverage | 1.2 x | 1.4 x |
| $, USD | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|
Net Income | (35.3 m) | (32.8 m) | (56 m) |
Depreciation and Amortization | 1.2 m | 2.2 m | 3.7 m |
Accounts Receivable | (6.7 m) | (11 m) | 7.3 m |
Inventories | (6.6 m) | (1.1 m) | (3.5 m) |
Accounts Payable | 4.6 m | 581 k | (970 k) |
Cash From Operating Activities | 58.7 m | (42.8 m) | (23.2 m) |
Cash From Investing Activities | (13.4 m) | (23 m) | (3.8 m) |
Cash From Financing Activities | 99 m | 2.6 m | 4.1 m |
Interest Paid | 534 k | 23 k |
| Y, 2016 | |
|---|---|
Financial Leverage | 1.4 x |
